English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/17898
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

DC FieldValueLanguage
dc.contributor.authorTriola Guillem, Gemma-
dc.contributor.authorFabriàs, Gemma-
dc.contributor.authorDragusin, Mihaela-
dc.contributor.authorNiederhausen, Lars-
dc.contributor.authorBroere, Roland-
dc.contributor.authorLlebaria, Amadeu-
dc.contributor.authorVan Echten-Deckert, Gerhild-
dc.identifier.citationMolecular Pharmacology 66(6): 1671-1678 (2004)en_US
dc.description8 pages, 9 figures.-- PMID: 15371559 [PubMed].-- Printed version published Dec 2004.en_US
dc.description.abstractDihydroceramide desaturase catalyzes the conversion of the innocuous precursor dihydroceramide into a highly bioactive product ceramide. We studied the effect of N-[(1R,2S)-2-hydroxy-1-hydroxymethyl-2-(2-tridecyl-1-cyclopropenyl)ethyl]octanamide (GT11), the first inhibitor of this enzyme, in primary cultured cerebellar neurons. Although desaturase was efficiently inhibited (IC50 of 23 nM), the compound lost its specificity at higher concentrations. From 5 µM upward, GT11 also decreased de novo sphingolipid biosynthesis. Studies with two differentially labeled radioactive analogs of GT11 support that the inhibitor itself and not a downstream metabolic product, interferes with sphingolipid biosynthesis. It is interesting that serine palmitoyltransferase activity decreased in the presence of high concentrations of GT11 in intact cells, but not when added directly into cell homogenates. However, suppression of enzyme transcription could not be detected. But at high concentrations GT11 provoked an accumulation of sphingosine-1-phosphate and especially of dihydrosphingosine-1-phosphate, suggesting a decreased activity of sphingosine-1-phosphate lyase. Enzyme activity measurements indeed supported this assumption. Thus, at higher concentrations, GT11 interferes with lyase activity, inducing an accumulation of sphingoid base phosphates that, in turn, down-regulate serine palmitoyltransferase activity. At low concentrations, however, GT11 is the first specific inhibitor of dihydroceramide desaturase described so far. Considering the proapoptotic and proinflammatory effect of ceramide, GT11 could also turn out to be a novel cell-protective agent.en_US
dc.description.sponsorshipThis study was supported by the Deutsche Forschungsgemeinschaft and the Spanish Ministry of Science and Technology (Grants BQU2002-00786 and BQU2002-03737). G.T. was financially supported by the Generalitat de Catalunya and Almirall Prodesfarma S.A.en_US
dc.format.extent22195 bytes-
dc.publisherAmerican Society for Pharmacology and Experimental Therapeuticsen_US
dc.subjectDihydroceramide desaturase inhibitoren_US
dc.subjectPrimary cultured cerebellar neuronsen_US
dc.subjectCell growth regulationen_US
dc.titleSpecificity of the dihydroceramide desaturase inhibitor N-[(1R,2S)-2-hydroxy-1-hydroxymethyl-2-(2-tridecyl-1-cyclopropenyl)ethyl]octanamide (GT11) in primary cultured cerebellar neuronsen_US
dc.description.peerreviewedPeer revieweden_US
Appears in Collections:(IQAC) Artículos
Files in This Item:
There are no files associated with this item.
Show simple item record

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.